Objectives: To gain further insight into the defence mechanisms against triclosan in a mutant derived from an Escherichia coli strain carrying the triclosan-resistant target enzyme, FabI(G93V).
Introduction
Triclosan [5-chloro-2-(2,4,-dichlorophenoxy) phenol] has been widely used for .30 years as a broad-spectrum antibacterial agent, especially for personal healthcare products, such as soaps and toothpastes, fabrics, plastics and paints. 1, 2 Triclosan has a broad range of activity against many microorganisms, e.g. Escherichia coli, 3 Staphylococcus aureus, 4 Mycobacterium tuberculosis and Mycobacterium smegmatis, 5 and even against higher organisms such as Plasmodium falciparum and Toxoplasma gondii. 6 It has been reported to inhibit the growth of these triclosan-susceptible organisms by blocking lipid synthesis, specifically by inhibiting an NADH-dependent enoyl-acyl carrier protein reductase. 3, 4, 7 However, Pseudomonas aeruginosa and Streptococcus pneumoniae 4 are inherently resistant to triclosan. In P. aeruginosa, the resistance is due to a non-susceptible enoyl reductase, an outer membrane permeability barrier or efflux pump. 8 McMurry et al. 3 isolated mutants of E. coli in which triclosan resistance was associated with missense mutations in fabI, which encodes the enoyl-acyl carrier protein reductase. Among the triclosanresistant mutants, E. coli AGT11, which had a Gly93 Val mutation in fabI, FabI(G93V), showed a 95-fold higher MIC than the wildtype. On the basis of these results, Levy et al. 7 carried out structural analysis and inhibition experiments on a complex of E. coli FabI with triclosan and NAD + and found that a FabI -NAD + -triclosan ternary complex was formed by face-to-face interaction between the phenol ring of triclosan and the nicotinamide ring of NAD + in the active site of FabI. In contrast to intact FabI, overexpression of FabI(G93V) conferred greater triclosan resistance by preventing formation of the FabI-NAD + -triclosan ternary complex. 9 However, earlier studies by several groups strongly suggested that the antibacterial effects of triclosan are mediated at least in part through its membranotropic effects, resulting in destabilized structures that compromise the functional integrity of cell membranes without inducing lysis (disruption). 10 -13 Other studies have shown that overexpression of marA, soxS or acrAB results in reduced susceptibility to triclosan in E. coli.
14 Triclosan was also found to be a multitarget inhibitor that inhibits F-ATPase, weak acid transmembrane proton carriers, glycolytic enzymes [pyruvate kinase, lactic dehydrogenase, aldolase and the phosphotransferase system (PTS)] and biofilm formation in mutants of the oral pathogen Streptococcus lacking a triclosan-sensitive FabI. 15 These results imply that triclosan may have multiple targets in bacteria and other mechanisms of action in addition to the inhibition of lipid biosynthesis.
Motivated by the possibility of the presence of additional targets for, or defence mechanisms against, triclosan, and the knowledge that no significant resistance problem has arisen even after extensive use of this agent, we tried to identify targets other than FabI and to investigate the defence mechanisms. To accomplish this, we replaced intact fabI with triclosanresistant fabI(G93V) in the genome of E. coli imp4231, which contains a 23 codon deletion allele in imp (increased membrane permeability), a gene encoding a protein essential for outer membrane assembly.
16 E. coli imp4231 shows increased sensitivity to antibiotics and detergents 17 and has frequently been used to study the mechanisms of action of compounds that poorly penetrate the outer membrane of wild-type E. coli. 18, 19 Using this E. coli imp4231 FabI(G93V) strain, we performed nitrosoguanidine (NTG) mutagenesis and generated E. coli imp4231 FabI(G93V) treated with NTG, called E. coli IFNs, displaying higher MICs of triclosan (MIC 60 -80 mg/L) than the parent strain (MIC 8 mg/L). We then identified the genes overexpressed in E. coli IFN4 using DNA microarray analysis. Many genes involved in the biosynthesis of inner/outer membrane proteins, pore (porin)/transporters, reductases/dehydrogenases, chaperones and stress response regulators were overexpressed. It would be particularly interesting to investigate these genes conferring on cells a higher MIC of triclosan because the practical dose of triclosan (.100 mg/L) far exceeds its MIC for wild-type strains of E. coli.
Materials and methods

Bacterial strains, plasmids, enzymes and chemicals
To construct E. coli imp4231 FabI(G93V), we used E. coli imp4231 obtained from Dr Silhavy and the Red recombination system with plasmids pKD3 and pKD46, which were obtained from Datsenko and Wanner. 20 The plasmid was electroporated by a Gene Pulser system (Bio-Rad, Hercules, CA, USA). All primers and the PCR pre-mix were purchased from Bioneer (Daejeon, Korea). For all experiments we used Luria-Bertani (LB) liquid or agar medium containing 10 mg/L ampicillin or 6 mg/L chloramphenicol where appropriate. L-Arabinose was added to a final concentration of 10 mM, and triclosan to final concentrations of 2 and 50 mg/L to cultures of E. coli imp4231 and E. coli imp4231 FabI(G93V), respectively.
Construction of E. coli imp4231 FabI(G93V)
A linear DNA cassette [fabI(G93V)-Cm R ] containing a single mutation, GGT to GTT, at codon 93 of fabI [fabI(G93V)] with an upstream chloramphenicol resistance gene (Cm R ) marker was constructed by recombinant PCR using the E. coli imp4231 chromosome and plasmid pKD3 as templates. The fabI(G93V)-Cm R cassette, flanked by 50 nucleotide homology extensions specific to sequences normally flanking the wild-type fabI, was electrotransferred into E. coli imp4231 harbouring pKD46 to replace intact fabI with fabI(G93V), and the transformants were selected on LB plates containing 6 mg/L chloramphenicol ( Figure 1 ). PCR was used to confirm that the fabI(G93V)-Cm R cassette had been inserted at the correct site, deploying a pair of primers (25 pmol) that flank the endpoints of fabI and another pair (25 pmol) specific for the internal DNA sequences of fabI, with E. coli imp4231 and the candidate transformants as templates.
Construction of E. coli imp4231 FabI(G93V) mutants by NTG mutagenesis An overnight culture of E. coli imp4231 FabI(G93V) was diluted 1:100 in 100 mL of fresh LB broth and grown to exponential phase [optical density (OD) 600 ¼0.5]. NTG solution was added to a final concentration of 50 mg/mL and the culture was incubated for 40 min at 378C. The NTG-treated cells were harvested and washed four times with fresh LB medium. The pellets were resuspended in 25 mL of LB medium, incubated for 40 min at 378C and selected on LB plates containing 50 mg/L triclosan and 6 mg/L chloramphenicol, generating E. coli imp4231 FabI(G93V) NTG mutants, E. coli IFNs.
MICs of triclosan for strains
A Bioscreen C TM (Oy Growth Curves Ab, NJ, USA) was used to determine values at which growth of E. coli imp4231, E. coli imp4231 FabI(G93V) and E. coli IFN4 was inhibited under the given conditions. A 10 mL aliquot ( 1×10 6 cfu) of an overnight culture of these strains was inoculated in 0.4 mL of LB broth containing each series of triclosan concentrations and 6 mg/L chloramphenicol in the case of E. coli imp4231 FabI(G93V) and E. coli IFN4, and loaded on 96-well plates. After inoculation, the 96-well plates were incubated on Bioscreen C TM at 378C and the growth was monitored for 24 h. The accurate MICs for the strains were determined using various concentrations of triclosan as previously described. 21 One colony was selected from each fresh agar plate, inoculated into 3 mL of LB broth and incubated in a shaker at 225 rpm at 378C. The overnight cultures were diluted up to an OD 600 of 0.002, inoculated into 100 mL of LB containing various concentrations of triclosan and incubated in a shaker at 225 rpm at 378C for 20 h. OD 600 values were measured.
RNA isolation and preparation of labelled cDNA E. coli imp4231 FabI(G93V) and E. coli IFN4, which showed the highest MICs, were cultivated in 100 mL of LB broth containing 6 mg/L chloramphenicol with or without 50 mg/L triclosan and harvested in midlogarithmic growth phase (OD 600 ¼1.0). Each culture (3 mL, 7.5×10 8 cells) was mixed with 6 mL of RNAprotect Bacterial Reagent (Qiagen, Hilden, Germany). RNA was extracted using an RNeasy Mini Kit (Qiagen). The purified RNA (40 mg) was mixed with 2 mL of bacterial random primer (3 mg/mL), 10 mL of 5× First Strand Buffer (Invitrogen, CA, USA), 5 mL of 0.1 M dithiothreitol (DTT), 1 mL of 50× aminoallyl-dNTP mixture (0.5 mM each of dATP, dGTP, dCTP and dTTP), 1 mL of RNasin (40 U/mL) (Promega, WI, USA) and 2 mL of reverse transcriptase (200 U/mL) (Invitrogen), and was incubated at 428C for 1 h. After a further incubation with 1 mL of reverse transcriptase (200 U/mL) at 428C for 1 h, 16.5 mL of 1 M NaOH and 16.5 mL of 0.5 M EDTA were added to the mixture and incubated at 658C for 15 min to degrade the RNA. HCl (16.5 mL, 1 M) was added to neutralize the mixture. The synthesized cDNA mixtures were purified using Microcon YM-30 (Millipore, MA, USA) and eluted. The purified cDNA was mixed with 1 mL of 1 M Na 2 CO 3 (pH 9.0) and 2 mL of Cy3-OSu or Cy5-OSu (Amersham Pharmacia Biotech, NJ, USA) and incubated at room temperature for 1 h in the dark. The two labelled cDNA samples to be compared were purified using a QIAquick PCR purification kit (Qiagen), and the eluted cDNA was dried by SpeedVac.
Microarray hybridization and data analysis
The E. coli chip (Microbial Genomics & Applications Center, KRIBB, Korea) consisted of 4776 probes (70 nucleotides) specific for all E. coli open reading frames (ORFs). Prior to hybridization, microarray slides were washed twice with ethanol and double-distilled water (DDW) and incubated at 428C for 1 h in 50 mL of pre-hybridization buffer (25% formamide/5× SSC/0.1% SDS/10 mg/mL BSA). After two washes with DDW, the microarray slides were dried by centrifugation at 700 rpm for 5 min. The dried labelled probes were resuspended in 30 mL of hybridization buffer (25% formamide/5× SSC/0.1% SDS/10% dextran sulphate) and incubated at 958C for 5 min to denature the labelled Construction of E. coli imp4231 FabI(G93V). A linear DNA cassette containing a single mutation, GGT to GTT, at codon 93 of fabI, a chloramphenicol resistance gene (Cm R ) and two homology arms flanking fabI(G93V)-Cm R was constructed by recombinant PCRs. First, a fabI(G93V) fragment that contained a point mutation at the 93rd codon and its promoter region was generated by two PCRs, the first PCR with Fab-P1/FabI-mut-R primers and FabI-mut-F/FabI-pKD3-R primers, respectively, and the second recombinant PCR with PCR products from the first PCRs as template and FabI-P1/FabI-pKD3-R primers. FabI-P1 and FabI-pKD3-R primers contain a 50 bp homology region downstream of fabI and a 31 bp homology region of the 5 ′ region of Cm R , respectively. The Cm R fragment including its promoter region was amplified with a pKD3-F primer and a pKD3-P2 primer, containing a 50 bp homology region downstream of fabI. Finally, a recombinant PCR was performed with a fabI(G93V) fragment and a Cm R fragment as template, and FabI-P1 and pKD3-P2 primers, generating a fabI(G93V)-Cm R fragment (a). This linear DNA cassette was electrotransferred into E. coli imp4231 harbouring pKD46 to replace intact fabI with its mutated one, fabI(G93V), generating E. coli imp4231 FabI(G93V) (b). The primers used are as follows: FabI-P1 (5
probes. Each labelled probe was mixed and applied to the microarray slide and covered with a cover-slip. Hybridization was carried out in a humidified slide chamber (Corning, Victoria, Australia) submerged in a 428C water bath for .16 h. The cover-slips were removed by incubation for 1 min in wash buffer I (2× SSC and 0.1% SDS) pre-warmed to 428C, and the slides were washed sequentially in washing buffer I at 428C for 10 min in the dark, washing buffer II (0.1× SSC and 0.1% SDS) at room temperature for 10 min in the dark, and twice in washing buffer III (0.1× SSC) at room temperature for 1 min. Finally, the slides were dried by centrifugation at 700 rpm for 5 min and immediately scanned with a GenePix 4000B scanner (Axon Instruments, CA, USA). The resulting images were analysed using GenePix Pro 6.0 software (Axon Instruments), and the data were imported into Genespring software for further analysis. 
E. coli imp4213 fabI(G93V)
E. coli imp4213 Figure 2 . Growth inhibition of E. coli imp4231, E. coli imp4231 FabI(G93V) and E. coli IFN4 by triclosan. For the determination of the growth inhibition concentrations of triclosan for these strains, each series of triclosan concentrations prepared in LB was inoculated with 10 mL ( 1×10 6 cfu) of an overnight culture of these strains. After inoculation on 96-well plates, the plates were incubated on Bioscreen C TM at 378C for 24 h. MICs for E. coli imp4231, E. coli imp4231 FabI(G93V) and E. coli IFN4. For the determination of MICs for these strains, each series of triclosan concentrations prepared in 100 mL of LB was inoculated with diluted overnight cultures (OD 600 ¼0.002) of these strains. After inoculation, the cells were incubated in a shaker at 378C for 20 h.
Results
Construction of E. coli imp4231 FabI(G93V)
To generate a triclosan-resistant E. coli strain, we constructed E. coli imp4231 FabI(G93V) using a linear DNA cassette, fabI(G93V)-Cm R , that contains a single mutation, GGT to GTT, at codon 93 of fabI(G93V) and a Cm R cassette as a marker for the mutant allele, and a Red-mediated recombination system (Figure 1) . In this study, we used the E. coli imp4231 as the host because it is more sensitive to triclosan (MIC 0.02 mg/L) (Figures 2a and 3a) than wild-type strains such as E. coli W3110, E. coli MG1655 or E. coli DH5a (MIC 0.0625 mg/L). It has been reported that E. coli FabI(G93V) shows a 95-fold higher MIC than the wild-type. 3 First, the growth inhibition concentrations of triclosan against E. coli imp4231 FabI(G93V) were measured on Bioscreen C TM and the value at which growth was not observed under the tested condition was 4 mg/L, which is 200-fold higher than that of its parent strain, E. coli imp4231 (Figure 2b) . Furthermore, the accurate MIC of E. coli imp4231 FabI(G93V) against triclosan was measured by cultivating the strain in 100 mL of LB broth containing various concentrations of triclosan for 20 h, resulting in 8 mg/L (Figure 3b ) which is 400-fold higher than that of E. coli imp4231 (MIC 0.02 mg/L).
Mutant isolation through NTG mutagenesis
Mutants conferring higher resistance to triclosan than E. coli imp4231 FabI(G93V) were generated to reveal other defence mechanisms against triclosan. To obtain these mutants, E. coli imp4231 FabI(G93V) cultures were grown to exponential phase (OD 600 ¼0.5), treated with NTG so that 95% of the population was killed by exposure to NTG, and the surviving mutants were selected on LB plates containing 50 mg/L triclosan and chloramphenicol. Over 100 mutants were obtained. These mutants of E. coli imp4231 FabI(G93V) treated with NTG, named E. coli IFNs, showed higher MIC values in the range of 40 -80 mg/L. Among the various E. coli IFNs, we chose E. coli IFN4 because it displayed the highest MIC ( 80 mg/L), which is getting close to the concentration (.100 mg/L) of triclosan in use (Figures 2c and 3c) . To understand whether this increased MIC of triclosan is due to another mutation(s) in fabI, we first sequenced fabI from E. coli IFN4. Sequence analysis showed no change in either the promoter region or the structural gene. These results suggest that the increased MIC of triclosan for E. coli IFN4 is attributable to factors other than the well-known triclosan target fabI(G93V). Therefore, we analysed the differential gene expression profile between E. coli imp4231 FabI(G93V) and E. coli IFN4, and used DNA microarrays to identify genes differentially expressed in E. coli IFN4.
Differential gene expression profiles
In order to analyse the differences between E. coli imp4231 FabI(G93V) and E. coli IFN4, we performed four cultures of the two strains in the absence of triclosan and analysed the expression pattern. Each sample was hybridized on a wholegenome array which was printed twice on the upper and lower side of each slide, therefore giving a total of eight measurements per gene for each treatment. The correlation coefficients between the same spots on the upper and lower side of each slide were in the range of 0.93-0.98. The P value per individual gene showing a high fold change is ,0.04 (Table 1 ). The raw data including normalized fold values and P values of each experiments have been deposited at GEO (http://www.ncbi.nlm. nih.gov/geo/) under the accession number GSE17441. Genes up-regulated in E. coli IFN4 compared with E. coli imp4231 FabI(G93V) are shown in Table 1 . In general, genes encoding transporters, reductases/dehydrogenases, chaperones, metabolic enzymes and regulators showed 2.4-to 6.6-fold increases in expression. More specifically, .50% of the highly expressed genes encoded transporters or reductases/dehydrogenases. The glucitol/sorbitol PTS (srlAEBD), nitrate/nitrite transporter (narU), outer membrane porin (ompF and nmpC) and predicted transporters (ykgG and ydjXYZ) were highly expressed. Some inner and outer membrane proteins (yagU, ychH and yccM) that may be involved in unknown transport systems were also highly expressed. Other highly expressed genes included many of those encoding reductases (narGHJI, garR, hcp and yeaA) and dehydrogenases (fdnGHI, ykgEF, garD, gldA and yeiQ), and some global regulators involved in biofilm formation (bssR), universal stress response (uspA), cell morphogenesis and wall metabolism (ytfE) and predicted DNA-binding transcriptional regulators (ymfTL, ttdR and ygiP).
Discussion
DNA microarray analysis is a powerful tool for measuring differential gene expression profiles on a genome-wide scale. In this study, we monitored the differential gene expression profile of E. coli IFN4, a mutant with a very high MIC of triclosan obtained from an E. coli strain carrying the triclosan-resistant target enzyme, FabI(G93V).
In E. coli IFN4, genes encoding transporters, reductases/dehydrogenases and regulators were up-regulated. It is quite interesting to note that many reductases (narGHJI, garR, hcp and yeaA) and dehydrogenases (fdnGHI, ykgEF, garD, gldA and yeiQ) which use NAD(P) as a cofactor were highly expressed. It has been known that a FabI-NAD + -triclosan ternary complex is formed by face-to-face interaction between the phenol ring of triclosan and the nicotinamide ring of NAD + in the active site of FabI (enoyl-acyl carrier protein reductase). 7 It is therefore possible that highly expressed reductases and dehydrogenases could bind triclosan, thus lowering the effective triclosan concentration. Concerning up-regulated porins and transporters, they can either provide an efflux mechanism to export triclosan from the cells or accelerate the import of triclosan into the cytoplasm before the cell membrane is destabilized, thereby contributing to increasing the MICs of triclosan. Global regulators including uspA, bssR, ytfE, ymfTL, ttdR and ygiP were also up-regulated; they would modulate the expression of their cognate genes, thus indirectly contributing to the cells' increased triclosan tolerance.
In summary, it is conceivable that triclosan resistance could be generated by the following mechanisms: (i) by importing triclosan into the cytoplasm using highly expressed porins and transporters before the membrane is destabilized, and providing efflux mechanisms to export the drug from the cells; (ii) by expressing reductases and dehydrogenases as proteins that can interact with or capture the transferred triclosan, thus lowering the effective triclosan concentration; and, finally, (iii) by increasing the expression of various regulators that might be involved in increasing resistance to triclosan. These results may provide critical clues for further investigation of the specific mechanism(s) of action of triclosan and the defence mechanisms of cells against triclosan, which has been widely used for more than four decades. 
Transparency declarations
None to declare.
